ReviewMetabolites2022

The Cardiovascular Benefits and Infections Risk of SGLT2i versus Metformin in Type 2 Diabetes: A Systemic Review and Meta-Analysis.

Chunmei Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.